14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Wednesday, 24th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Jul 10, 2023 $0.320 $0.365 $0.290 $0.360 210 703
Jul 07, 2023 $0.318 $0.340 $0.290 $0.338 13 081
Jul 06, 2023 $0.325 $0.385 $0.325 $0.370 27 457
Jul 05, 2023 $0.359 $0.368 $0.325 $0.361 49 110
Jul 03, 2023 $0.370 $0.380 $0.320 $0.380 31 170
Jun 30, 2023 $0.386 $0.390 $0.360 $0.370 14 266
Jun 29, 2023 $0.360 $0.370 $0.320 $0.360 37 199
Jun 28, 2023 $0.330 $0.360 $0.320 $0.360 22 508
Jun 27, 2023 $0.310 $0.363 $0.310 $0.350 37 402
Jun 26, 2023 $0.350 $0.370 $0.335 $0.335 12 994
Jun 23, 2023 $0.378 $0.378 $0.320 $0.350 87 832
Jun 22, 2023 $0.361 $0.390 $0.350 $0.353 21 699
Jun 21, 2023 $0.321 $0.370 $0.321 $0.361 9 596
Jun 20, 2023 $0.340 $0.390 $0.321 $0.350 8 929
Jun 16, 2023 $0.337 $0.359 $0.337 $0.340 16 380
Jun 15, 2023 $0.400 $0.400 $0.336 $0.375 18 774
Jun 14, 2023 $0.380 $0.400 $0.331 $0.400 3 960
Jun 13, 2023 $0.350 $0.390 $0.305 $0.390 18 627
Jun 12, 2023 $0.350 $0.380 $0.300 $0.350 48 744
Jun 09, 2023 $0.418 $0.440 $0.371 $0.371 19 100
Jun 08, 2023 $0.440 $0.520 $0.375 $0.440 67 366
Jun 07, 2023 $0.245 $0.493 $0.230 $0.440 325 563
Jun 06, 2023 $0.230 $0.280 $0.212 $0.245 232 066
Jun 05, 2023 $0.250 $0.360 $0.181 $0.230 720 093
Jun 02, 2023 $0.400 $0.525 $0.150 $0.300 229 266
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT